Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach

BACKGROUND: Immune checkpoint inhibitors (ICIs) have particular, immune-related adverse events (irAEs), as a consequence of interfering with self-tolerance mechanisms. The incidence of irAEs varies depending on ICI class, administered dose and treatment schedule. The aim of this study was to define...

Descripción completa

Detalles Bibliográficos
Autores principales: Botticelli, Andrea, Cirillo, Alessio, Pomati, Giulia, Cortesi, Enrico, Rossi, Ernesto, Schinzari, Giovanni, Tortora, Giampaolo, Tomao, Silverio, Fiscon, Giulia, Farina, Lorenzo, Scagnoli, Simone, Pisegna, Simona, Ciurluini, Fabio, Chiavassa, Antonella, Amirhassankhani, Sasan, Ceccarelli, Fulvia, Conti, Fabrizio, Di Filippo, Alessandra, Zizzari, Ilaria Grazia, Napoletano, Chiara, Rughetti, Aurelia, Nuti, Marianna, Mezi, Silvia, Marchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264536/
https://www.ncbi.nlm.nih.gov/pubmed/36869232
http://dx.doi.org/10.1007/s00262-023-03384-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264536/
https://www.ncbi.nlm.nih.gov/pubmed/36869232
http://dx.doi.org/10.1007/s00262-023-03384-9

Ejemplares similares